Our congratulations to F1000 Section Head Tony Hunter, who has been awarded the 2014 Royal Medal for biological sciences by the Royal Society. Tony Hunter is director of Salk’s NCI-designated Cancer Center and has been on the F1000 Faculty since its conception in 2001*. He is also a fellow of the Royal Society and a…
We are delighted to welcome Michael Eisen to F1000’s International Advisory Board. Michael Eisen initially joined F1000 in September 2001 as a Faculty Member in the Genomics & Genetics Faculty. Best known for being a co-founder of PLOS (Public Library of Science) in 2000, he is also a professor of Genetics, Genomics and Development at…
Here are the week’s most popular tweets from @F1000, as well as some other interesting picks from the rest of Twitter…
Here are this week’s most popular tweets on the @F1000 feed, as well as some other interesting picks from the rest of Twitter…
Pharmacology Faculty Member Mark Millan has won the 2014 Ariens Prize. The award is an annual prize organized by the Dutch Pharmacological Society in memory of the Dutch pharmacologist, Everhardus Jacobus Ariens, who made important contributions to understanding of the function of receptors in the field of pharmacology. Prize-winners are invited to present the Ariens…
Here are the week’s most popular tweets from @F1000, as well as other interesting gems from the rest of Twitter…
Guest post by F1000 Specialist Sowmini Kumaran from Rutgers, USA who recently moved to India seeking industrial job opportunities in India.
Here are this week’s most popular tweets on the @F1000 feed, as well as some other interesting picks from the rest of Twitter…
It is with great sadness that we note the tragic death of Professor Joep Lange, F1000Prime Section Head for HIV Infection & AIDS: Clinical, in the Malaysian Airline flight MH17 disaster yesterday. Professor Lange was Professor of Internal Medicine at the Academic Medical Centre, University of Amsterdam, and held a number of prestigious positions, including…
We regretfully note the death of Carlos F. Barbas III, who passed away at the age of 49 last month after suffering from a rare form of medullary thyroid cancer. An award-winning and renowned organic chemist, Carlos worked towards developing novel drugs to treat human disease; among his accomplishments are the development of new classes…
